Clinical Trial Update: A Phase II Study of Cyberknife Radiosurgery for Renal Cell Carcinoma [NA]

View source ↗

Summary

A Phase II study of CyberKnife radiosurgery for renal cell carcinoma is currently recruiting at Beth Israel Deaconess Medical Center.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Renal Cell Carcinoma

Snippet

Sponsor: Beth Israel Deaconess Medical Center | Conditions: Renal Cell Carcinoma | NA | Status: RECRUITING